MENUNews Archive
Date: 06/23/2021
Erika Newman, M.D., has been named the Rogel Cancer Center's first associate director for diversity, equity, inclusion and justice.
Date: 06/23/2021
Leukemia stem cells are rare cells that can renew themselves while continuing to generate malignant cells known as leukemic blasts. These cells are difficult to eradicate using chemotherapy drugs and frequently lead to recurrence of leukemia.
Date: 06/21/2021
While patient survival has been extended by modern drugs that block the production or action of male hormones that fuel prostate cancer — androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, and abiraterone — eventually these drugs stop working
Date: 06/17/2021
As the coronavirus pandemic disrupted our workplaces, schools and families, studies have shown that women bore a disproportionate burden. The pandemic has been especially challenging for women in medicine, a field that’s already had slow progress in gender equity.
Date: 06/15/2021
Having an Erdheim-Chester Disease (ECD) referral center located in this region will help the 12 Michigan-based patients currently registered with ECDGA.
Date: 06/14/2021
Swim Across America - Motor City Mile will be July 9, 2021, in Detroit, with proceeds supporting research at the Rogel Cancer Center.
Date: 06/09/2021
The University of Michigan is one of eight sites around the country that will enroll patients in a clinical trial to evaluate the safety and efficacy of a technology that uses ultrasound to treat liver tumors.
Date: 06/09/2021
By sequencing the RNA of individual cells within multiple benign and cancerous kidney tumors, researchers have identified the cells from which different subtypes originate, the pathways involved and how the tumor microenvironment impacts cancer development and response to treatment.
Date: 06/08/2021
ApoE, an apolipoprotein known to play roles in cardiovascular disease and Alzheimer’s, is elevated in the blood of people with pancreatic adenocarcinoma, according to this new research.
Date: 06/07/2021
The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.